The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effectiveness of capecitabine plus oxaliplatin for advanced colon cancer: A public hospital experience.
Carrie Luu
No relevant relationships to disclose
Johnathan Velasquez
No relevant relationships to disclose
Amy Kaji
No relevant relationships to disclose
Bruce E. Stabile
No relevant relationships to disclose
Beverley A Petrie
No relevant relationships to disclose
Ravin Kumar
No relevant relationships to disclose
Amy Caton
No relevant relationships to disclose
Joseph Kim
No relevant relationships to disclose
Steven L. Chen
No relevant relationships to disclose
Byrne Lee
No relevant relationships to disclose